1. Sekiya A, Takasawa K, Arai Y, Horike S, Akutsu H, Umezawa A, Nishino
K. "Variation
of DNA methylation on the IRX1/2 genes is responsible for the neural
differentiation propensity in human induced pluripotent stem cells" Regenerative Therapy. 21, 620-630, 2022.
2. Shionoya K, Suzuki T, Takada M, Sato K, Onishi S, Dohmae N, Nishino
K, Wada T, Linhardt RJ, Toida T, Higashi K. "Comprehensive analysis of
chondroitin sulfate and aggrecan in the head cartilage of bony fishes:
Identification of proteoglycans in the head cartilage of sturgeon" Int J
Biol Macromol. 208, 333-342, 2022.
3. Nishino K, Takasawa
K, Okamura K, Arai Y, Sekiya A, Akutsu H, Umezawa A. "Identification of an
epigenetic signature in human induced pluripotent stem cells using a linear
machine learning model." Human Cell. 34, 99-110, 2021.
4. Sekiya A, Takasawa K, Arai Y, Torisu S, Nishino K. "Dog
Steroidogenic Factor-1: Molecular cloning and analysis of epigenetic
regulation" J Vet Med Sci. 82(6): 681-689, 2020.
5. Arai Y, Umeyama K, Okazaki N, Nakano K, Nishino K, Nagashima H, Ohgane
J. “DNA methylation ambiguity in the Fibrillin-1 (FBN1) CpG island shore
possibly involved in Marfan syndrome” Scientific Reports. 10:5287.
2020.
6. Nishino K, Arai Y,
Takasawa k, Toyoda M, Yamazaki-Inoue M, Sugawara T, Akutsu H, Nishimura K,
Ohtaka M, Nakanishi M, Umezawa A. “Epigenetic-scale comparison of human iPSCs
generated by retrovirus, Sendai virus or episomal vectors” Regenerative Therapy. 9: 71-78. 2018.
7. Takasawa K, Arai Y, Yamazaki-Inoue M, Toyoda M, Akutsu H, Umezawa
A, Nishino
K. “DNA hypermethylation enhanced telomerase reverse
transcriptase expression in human induced pluripotent stem cells” Human Cell. 31(1): 78-86. 2018.
8. Wakitani S, Yokoi D, Hidaka Y, Nishino K. “The differentially DNA-methylated region
responsible for expression of runt-related transcription factor 2”. J Vet Med Sci. 79(2):230-237. 2017.
9. Nishino K, Umezawa A. “DNA methylation dynamics in human induced pluripotent stem cells”. Hum Cell. 29(3): 97-100. 2016. Review.
10. Imai H, Kano K, Fujii W, Takasawa K, Wakitani S, Hiyama M, Nishino K,
Kusakabe KT, Kiso Y. “Tetraploid Embryonic Stem Cells Maintain Pluripotency
and Differentiation Potency into Three Germ Layers”.
PLoS One. 10(6): e0130585. 2015.
11. Kaneko S, Bonasio R, Saldaña-Meyer R, Yoshida T, Son J, Nishino
K, Umezawa A, Reinberg D. “Interaction
between JARID2 and Noncoding RNAs Regulate PRC2 Recruitment to Chromatin”. Mol Cell. 53(2):290-300. 2014.
12. Yamagata Y, Nishino K, Takaki E, Sato S, Maekawa R, Nakai A, Sugino N. “Genome-wide DNA methylation profiling in
cultured eutopic and ectopic endometrial stromal cells”.
PLoS One. 9(1):e83612. 2014.
13. Wakitani S*, Torisu S*, Yoshino T, Hattanda K, Yamato O, Tasaki R,
Fujita H, Nishino K. “Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria
type II) with a novel mutation of electron transfer flavoprotein-dehydrogenase
in a cat”. JIMD Reports. 13:43-51. 2014.
*These authors contributed equally to this work.
14. Yugawa T, Nishino K, Ohno SI, Nakahara T, Fujita M, Goshima N,
Umezawa A, Kiyono T. “Non-canonical
NOTCH signaling limits self-renewal of human epithelial and iPS cells through
ROCK activation.” Mol Cell
Biol. 33(22):4434-47. 2013.
15. Hiura H, Toyoda M, Okae H, Sakurai M, Miyauchi N, Sato A, Kiyokawa
N, Okita H, Miyagawa Y, Akutsu H, Nishino
K, Umezawa A, Arima T. “Stability of
genomic imprinting in human induced pluripotent stem cells”. BMC
Genet. 14(1):32. 2013.
16. Michael IP, Monetti C, Chiu AC, Zhang P, Baba T, Nishino K,
Agha-Mohammadi S, Woltjen K, Sung HK, Nagy A. “Highly efficient site-specific transgenesis in
cancer cell lines”. Mol Cancer. 11(1):89. 2012.
17. Sugawara T, Nishino K, Umezawa A, Akutsu H. “Investigating cellular identity and manipulating cell fate using
induced pluripotent stem cells”. Stem Cell Res Ther.
3:8. 2012. Review
18. Nishino K, Hattori N,
Sato S, Arai Y, Tanaka S, Nagy A, Shiota K. “Non-CpG methylation occurs in the regulatory
region of Sry gene”. J Reprod Dev. 57(5), 586-593. 2011.
19. Nishino K, Toyoda M,
Yamazaki-Inoue M, Fukawatase Y, Chikazawa E, Sakaguchi H, Akutsu H, Umezawa A. “DNA methylation dynamics in human induced pluripotent stem cells
over time”. PLoS Genetics 7(5): e1002085. 2011.
20. Saito S, Onuma Y, Ito Y, Tateno H, Toyoda M, Akutsu H, Nishino K,
Chikazawa E, Fukawatase Y, Miyagawa Y, Okita H, Kiyokawa N, Shimma Y, Umezawa
A, Hirabayashi J, Horimoto K, Asashima M. “Possible linkages between the inner and outer
cellular states of human induced pluripotent stem cells.” BMC Syst Biol 5 Suppl 1: S17. 2011.
21. Monetti C, Nishino K, Biechele S, Zhang P, Baba T, Woltjen K,
Nagy A. “PhiC31 integrase facilitates genetic approaches
combining multiple recombinases.” Methods. 53, 380-5. 2011.
22. Nishino K, Toyoda M, Yamazaki-Inoue
M, Makino H, Fukawatase Y, Chikazawa E, Takahashi Y, Miyagawa Y, Okita H,
Kiyokawa N, Akutsu H, Umezawa A.“Defining Hypo-Methylated Regions of Stem
Cell-Specific Promoters in Human iPS Cells Derived from Extra-Embryonic Amnions
and Lung Fibroblasts.” PLoS One 5(9): e13017. 2010.
23. Nagata S, Toyoda M, Yamaguchi S, Hirano K, Makino H, Nishino K,
Miyagawa Y, Okita H, Kiyokawa N, Nakagawa M, Yamanaka S, Akutsu H, Umezawa A,
Tada T. “Efficient reprogramming of human and mouse
primary extra-embryonic cells to pluripotent stem cells.” Genes Cells. 14, 1395-404. 2009.
24. Makino H, Toyoda M, Matsumoto K, Saito H, Nishino K,
Fukawatase Y, Machida M, Akutsu H, Uyama T, Miyagawa Y, Okita H, Kiyokawa N,
Fujino T, Ishikawa Y, Nakamura T, Umezawa A.“Mesenchymal to embryonic incomplete transition of human cells by
chimeric OCT4/3 (POU5F1) with physiological co-activator EWS.” Exp Cell Res. 315, 2727-40. 2009.
25. Hattori N, Imao Y, Nishino K, Hattori N, Ohgane J, Yagi S, Tanaka S,
and Shiota K. “Epigenetic regulation of Nanog gene in embryonic
stem and trophoblast stem cells.” Genes Cells. 12, 387-396. 2007.
26. Nakamura K, Murata C, Ito M, Iwamori T, Nishimura S, Hisamatsu S,Sonoki S, Nakayama A, Suyama E, Kawasaki H,
Taira K, Nishino
K, and Tachi C. “Design of hammerhead ribozymes that cleave
murine Sry mRNA in vitro and in vivo.” J Reprod Dev. 52, 73-80. 2006.
27. Ko Y.G, Nishino K, Hattori N, Arai Y, Tanaka S, and Shiota
K. "Stage-by-stage change in DNA methylation status of Dnmt1 locus during
mouse early development." J Biol Chem 280, 9627-9634.2005.
28. Nishino K, Hattori N,
Tanaka S, and Shiota K. "DNA methylation-mediated control of Sry gene
expression in mouse gonadal development." J Biol Chem 279,
22306-22313.2004.
29. Hattori N, Nishino K, Ko Y.G, Ohgane J, Tanaka S, and Shiota K.
"Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells
and trophoblast stem cells." J Biol Chem 279, 17063-17069. 2004.
30. Yokouchi K, Ito M, Nishino K, Yamanouchi K, Naito K, Suzawa M, Kato S,
Hakamata Y, Endo H, and Tojo H. "Stage-specific regulatory element of
mouse Sry gene." Mol Reprod Dev 64, 389-396. 2003.
31. Shiota K, Kogo Y, Ohgane J, Imamura T, Urano A, Nishino K,
Tanaka S, and Hattori N. "Epigenetic marks by DNA methylation specific to
stem, germ and somatic cells in mice." Genes Cells 7, 961-969. 2002.
32. Nishino K, Yamanouchi
K, Naito K, and Tojo H. "Matrix metalloproteinases regulate mesonephric
cell migration in developing XY gonads which correlates with the inhibition of
tissue inhibitor of metalloproteinase-3 by Sry." Dev Growth Differ 44,
35-43. 2002.
33. Nishino K, Yamanouchi
K, Naito K, and Tojo H. "Characterization of mesonephric cells that
migrate into the XY gonad during testis differentiation." Exp Cell Res
267, 225-232. 2001.
34. Nishino K, Kato M,
Yokouchi K, Yamanouchi K, Naito K, and Tojo H. "Establishment of fetal
gonad/mesonephros coculture system using EGFP transgenic mice." J
Exp Zool 286, 320-327. 2000.
35. Hirota O, Nishino K, Toyooka Y, Kodama T, Tanaka S, Yamanouchi
K. Tojo H, Tachi C. "Effects of Transfected Human and Mouse SRY/Sry Genes
upon the Expression of Hypothetical SRY-Cascade Genes in Cultured Mouse Sertoli
Cell Line, TM-4." J Reprod Dev 42, 255-263. 1996.
総説・著書
1.
関谷麻杜, 鳥巣至道, 西野光一郎: "コンパニオンアニマル再生医療における間葉系幹細胞 -自験例を中心に", 医学のあゆみ,
Vol.272, 1075-1080, 2020.
2. 高澤建, 新井良和, 西野光一郎:「第6節 機械学習とiPS細胞研究から得られるバイオビッグデータの融合」, 再生医療の開発戦略と最新研究事例集, （株）技術情報協会, 2019.
3. 梅澤明弘, 西野光一郎: 「再生医療」, エピジェネティクスキーワード事典, 235-241, 2013.
4. 梅澤明弘, 西野光一郎: "エピジェネティクスと病気「再生医療とエピジェネティクス」", 遺伝子医学MOOK, 第25巻, 2013.
5. Nishino K and Umezawa
A: “Induced Pluripotent Stem Cells from Human Extra-Embryonic Amnion
Cells: Role of DNA Methylation in Maintaining Stemness” Stem Cells and Cancer Stem Cells. Vol. 4, 59-65, 2012.
6. 西野光一郎, 梅澤明弘: "TOPICS再生医学「iPS細胞におけるメチル化動態」", 医学のあゆみ, Vol.243, 321-322, 2012.
7. 西野光一郎, 梅澤明弘:"幹細胞のメディカルサイエンス「iPS細胞とゲノムメチル化ダイナミクス」", 実験医学増刊, 第30巻, 1556-1561, 2012.
8. 西野光一郎, 梅澤明弘: "次世代iPS医療「iPS細胞とゲノムメチル化」", 医学のあゆみ, Vol.239, 1259-1264, 2011.
9. 梅澤明弘, 西野光一郎: "エピジェネティクスと疾患「再生医療とエピジェネティクスの接点」", 実験医学増刊, 第28巻, 2546-2551, 2010.
10. 西野光一郎, 梅澤明弘: "広がる’エピジェネティック疾患'研究の世界「エピジェネティクスと再生医療」", 医学のあゆみ, Vol.225, 588-592, 2008.
11. 梅澤明弘, 西野光一郎: "エピジェネティクス-最近の動向と疾患—各種疾患におけるエピジェネティクス研究の新展開「再生医療とエピジェネティクス」", 最新医学, 第63巻, 833-841, 2008.
12. 塩田邦郎, 田中智, 服部中, 大鐘潤, 今村拓也, 西野光一郎, 鈴木雅子, 小田真由美, 服部奈緒子, 冨川順子, ユリアクレメンスカ, 岩谷美沙:
"DNAメチル化研究法", 学会出版センター, 2006.
13. Nishino K, Ohgane J,
Suzuki M, Hattori N and Shiota K: "Methylation in Embryonic Stem cells in
vitro." Methods Mol Biol. Vol. 329, 421-425, 2006.
14. 西野光一郎, 塩田邦郎："エピジェネティクスと遺伝子発現機構「DNAメチル化による発生プログラム」", 実験医学増刊, 第21号, 1499-1507, 2003.